Navigation Links
Migraine Medical Device, Cefaly, Shows Better Long-Term Patient Compliance than Migraine Medication
Date:1/6/2016

NEW YORK, Jan. 6, 2016 /PRNewswire/ -- CEFALY Technology, the creators of the first FDA-approved trigeminal nerve stimulation device specifically authorized to prevent migraine attacks, releases data about the compliance of the device by patients suffering from migraine and compares it with the compliance of preventive migraine medication. 

CEFALY Technology collected data on 14,745 migraine patients who acquired the device between March 2014 and October 2015, a period of 19 months. Knowing that the device is used with an electrode that has to be replaced every month, the company was able to assess the compliance of the treatment based on the recurrent orders of electrodes. If all patients where using the device daily, in accordance to their doctor's recommendation, the compliance would be 100%, but the actual electrode consumption reveals that the compliance is 72.4%, which is twice the compliance rate usually reported for oral preventive migraine medication.

"This is a great confirmation that the Cefaly is a better solution than medications for migraine prophylaxis," said Dr. Pierre Rigaux, chief executive officer of CEFALY Technology, the maker of the device. "Not only does the high safety and the unlikely yet minor side effects explain the high compliance, the patient satisfaction for the efficacy does too. With the recent published clinical trials and the newest data from several clinical trials in the US, this compliance data demonstrates that Cefaly is becoming the first-line treatment for patients who suffer from frequent migraine."

In March 2014, the FDA approved Cefaly. The prescription-only, headband-like, device uses tiny electrical impulses to stimulate the trigeminal nerve to reduce the frequency and intensity of migraines. At the time, the FDA reached its decision using data from a randomized double blinded clinical trial implemented in five university clinics; as well as a patient satisfaction study of 2,313 Cefaly users.

About CEFALY Technology
CEFALY Technology is a Belgium-based company, with US offices based in Wilton, Connecticut, specializing in electronics for medical applications. It has developed external cranial stimulation technology for applications in the field of neurology; in particular for treating migraines. For more information, visit http://www.cefaly.us. Find Cefaly on Twitter: @Cefaly and on Facebook: http://www.facebook.com/CefalyEN.

Media Contact: Maria Coder
646-559-8530
m.coder@cefaly.us


'/>"/>
SOURCE CEFALY Technology
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Holy Name Medical Center Treats Migraine Headaches At Dedicated Center
2. Charleston Laboratories, Inc. Announces Successful Completion of Pre-IND Meeting on New Migraine Treatment CL-H1T
3. PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M
4. CoLucid Pharmaceuticals and ILDONG Pharmaceutical Enter into a Distribution and Supply Agreement for Lasmiditan, a Novel Agent for Acute Migraine
5. LipiGesic M stands alone among over-the-counter migraine medications based on recently released American Headache Society recommendations
6. Increasing Use of Allergans Botox and the Launch of Novel Nontriptan Products Will Be Key Drivers of Migraine Market Growth Through 2022
7. Labrys Biologics Initiates Two Phase 2 Studies of LBR-101 for the Prevention of Chronic and Episodic Migraine
8. Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
9. PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
10. Cytogel Pharma, LLC. Announces Presentation at the 8th Annual Pain and Migraine Therapeutics Summit in Boston on September 24, 2014, Novel mu opioid mechanisms for the potent analgesic Cyt-1010 distinguish it from morphine
11. Game Changing Migraine Medication To Be Available November 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
(Date:9/12/2017)... Sept. 12, 2017   EcoVadis , the leading platform for environmental, ... first annual edition of its Global CSR Risk and Performance Index. The ... EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points across ... ... ...
(Date:9/12/2017)...  ValGenesis Inc., the global leader in Enterprise ... announce the appointment of Dr. Ajaz Hussain ... Directors and Chairman of Advisory Board beginning September ... to manage their entire validation lifecycle process electronically ... process. Furthermore, ValGenesis VLMS enables rigorous compliance, helps ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... ... , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to ... unique items from across the nation, this holiday-themed event will raise funds and awareness ... VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):